FPMAJ, JPMA “Truly Regret” Additional Price Cuts for Long-Listed, Generic Drugs

December 27, 2011
Takashi Shoda, chairman, Federation of Pharmaceutical Manufacturers’ Associations of Japan (FPMAJ), issued a comment on December 26 on the 2012 NHI price revision, saying that the decision to not include a full implementation and permanent introduction of the premium for...read more